Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes

Leukemia Research

Volumn 29, Issue 6, 2005, Pages 701-710

  Matsuo, Yoshinobu ^a   Drexler, Hans G ^b   Harashima, Akira ^a   Okochi, Ayumi ^a   Kojima, Kensuke ^c   Asakura, Shoji ^c   Tanimoto, Mitsune ^c   Orita, Kunzo ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

AML; Cell line; Differentiation; Leukemia; MDS; TNF

Indexed keywords

BIOCHEMICAL MARKER; CD61 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; FIBRINOGEN RECEPTOR; GROWTH FACTOR; MICROSOMAL AMINOPEPTIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ADVANCED CANCER; ARTICLE; B LYMPHOCYTE; BLAST CELL; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; DNA FINGERPRINTING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL; MACROPHAGE; MALE; MYELODYSPLASTIC SYNDROME; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; REFRACTORY ANEMIA; SUPERNATANT;

EID: 18044396519     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.11.024     Document Type: Article

References (31)

1. H.G. Drexler, Y. Matsuo, and RA.F. MacLeod Continuous hematopoietic cell lines as model systems for leukaemia-lymphoma research Leuk Res 24 2000 881 911
2. H.G. Drexler Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes Leuk Res 23 2000 109 115
3. M.L. Heaney, and D.W. Golde Myelodysplasia New Engl J Med 340 1999 1649 1660
4. J.M. Bennett, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, and H.R. Gralnick Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199
5. N.L. Harris, E.S. Jaffe, J. Diebold, G. Flandrin, K. Muller-Hermelink, and J. Vardiman World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 1999 3835 3849
6. J.G.J. Kaashoek, R. Mout, J.H.F. Falkenburg, R. Willemze, W.E. Fibbe, and J.E. Landegent Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure Lymphokine Cytokine Res 10 1991 231 235
7. Z.-B. Hu, W. Ma, M. Zaborski, R.A.F. MacLeod, H. Quentmeier, and H.G. Drexler Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3 Leukemia 10 1996 1025 1040
8. H.G. Drexler, and Y. Matsuo Guidelines for the characterization and publication of human malignant hematopoietic cell lines Leukemia 13 1999 835 842
9. Y. Matsuo, H.G. Drexler, M. Takeuchi, and K. Orita A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia Leuk Res 23 1999 731 740
10. Y. Matsuo, H.G. Drexler, M. Takeuchi, and K. Orita Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia Leuk Lymphoma 35 1999 513 526
11. Y. Matsuo, H.G. Drexler, C. Nishizaki, A. Harashima, S. Fukuda, and T. Kozuka Human bone marrow stroma-dependent myeloma cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma Br J Haematol 109 2000 54 63
12. Mitelman F, Karger S, editor. ISCN. An International System for Human Cytogenetic Nomenclature. Basel; 1995.
13. B. Häne, M. Tümmler, K. Jäger, L. Schleithoff, J.W.G. Janssen, and H.G. Drexler Differences in DNA fingerprints of continuous leukaemia-lymphoma cell lines from different sources Leukemia 16 1992 1129 1133
14. Y. Matsuo, C. Nishizaki, and H.G. Drexler Efficient DNA fingerprinting method for the identification of cross-contamination of cell lines Hum Cell 12 1999 149 154
15. Y. Matsuo, H.G. Drexler, A. Harashima, A. Okochi, Norio Shimizu, and K. Orita Transcription factor expression in cell lines derived from natural-killer-cell and natural killer-like T-cell leukaemia-lymphoma Hum Cell 17 2004 85 92
16. Y. Matsuo, R.A.F. MacLeod, K. Kojima, K. Kuwahara, A. Sakata, and H.G. Drexler A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia Leukemia 11 1997 2168 2174
17. Y. Matsuo, K. Okubo, S. Hagiwara, M. Takenaga, and M.M. Yokoyama A pan T-cell monoclonal antibody which cross-reacts with the cells of megakaryocytic lineage A.J. McMichael Leucocyte typing III 1987 Oxford University Press Oxford 231 234
18. A.E.G. Von Dem Borne, P.W. Modderman, N.J. Risseeuw-Bogaert, M.J.E. Bos, F.J. Visser, and J.G. Giltay Serological and biochemical studies with monoclonal antibodies against platelets A.J. McMichael Leucocyte typing III 1987 Oxford University Press Oxford 231 234
19. Y. Matsuo, T. Kamiya, S. Nakamura, N. Yamamoto, F. Uno, and M. Yoshida Characterization of 17 human immunodeficiency virus-1 carrier cell lines with T cell, myelomonocyte, or megakaryocyte lineages Proc Soc Exp Biol Med 202 1993 271 278
20. Y. Matsuo, H.G. Drexler, K. Kaneda, K. Kojima, Y. Ohtsuki, and M. Hara Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype Leuk Res 27 2003 165 171
21. S. Luna-Fineman, K.M. Shannon, and B.J. Lange Childhood monosomy. Part 7: Epidemiology, biology, and mechanistic implications Blood 85 1995 1985 1999
22. H.J. Olney, and M.M. Le Beau The cytogenetics and molecular biology of myelodysplastic syndromes JM. Bennett The myelodysplastic syndromes 2002 Marcel Dekker New York 89 119
23. B.J. Sugarman, B.B. Aggarwal, P.E. Hass, I.S. Figari, M.A. Palladino Jr., and H.M. Shepard Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro Science 230 1985 943 945
24. J. Le, and J. Vilcek Tumor necrosis factor and interleukin. Part 1: Cytokines with multiple overlapping biological activities Lab Invest 56 1987 234 248
25. C. Peetre, U. Gullberg, E. Nilsson, and I. Olsson Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor J Clin Invest 78 1986 1694 1700
26. S. Schutze, P. Scheurich, C. Schluter, U. Ucer, K. Pfizenmaier, and M. Kronke Tumor necrosis factor-induced changes of gene expression in U937 cells. Differentiation-dependent plasticity of the responsive state J Immunol 140 1988 3000 3005
27. K. Takeda, S. Iwamoto, H. Sugimoto, T. Takuma, N. Kawatani, and M. Noda Identity of differentiation inducing factor and tumour necrosis factor Nature 323 1986 338 340
28. M. Tsujimoto, Y.K. Yip, and J. Vilcek Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells Proc Natl Acad Sci USA 82 1985 7626 7630
29. D.G. Tenen, R. Hromas, J.D. Licht, and D.E. Zhang Transcription factors, normal myeloid development, and leukemia Blood 90 1997 489 519
30. R.P. DeKoter, and H. Singh Regulation of B lymphocyte and macrophage development by graded expression of PU.1 Science 288 2000 1439 1441
31. R. Dahl, J.C. Walsh, D. Lancki, P. Laslo, S.R. Iyer, and H. Singh Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor Nat Immunol 4 2003 1029 1036